I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Abitbol, V.
171
results:
Search for persons
X
Format
Online (171)
Mediatypes
Articles (Online) (109)
Bookchapter (Online) (2)
OpenAccess-fulltext (60)
Languages
english (146)
more...
french (14)
spanish (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
P1071 Patient preferences for adalimumab in inflammatory bo..:
Caron, B
;
Seksik, P
;
Buisson, A
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1925-i1925 , 2024
Link:
https://doi.org/10.1093/..
?
2
Risk of anti-TNF therapy on pregnancy, breastfeeding, live ..:
Bendaoud, S.
;
Nahon, S.
;
Beaugerie, L.
...
Digestive and Liver Disease. , 2024
Link:
https://doi.org/10.1016/..
?
3
P884 Patient satisfaction and experience after a switch to ..:
Bouguen, G
;
Gossec, L
;
Abitbol, V
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1627-i1627 , 2024
Link:
https://doi.org/10.1093/..
?
4
P903 Persistence, efficacy and tolerance of subcutaneous In..:
Mathieu, N
;
Heluwaert, F
;
Riviere, P
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1655-i1655 , 2024
Link:
https://doi.org/10.1093/..
?
5
P927 Long-term outcomes of risankizumab in Crohn's disease:..:
Fumery, M
;
Caron, B
;
Hébuterne, X
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1686-i1686 , 2024
Link:
https://doi.org/10.1093/..
?
6
DOP89 Impact of biologics on the risk of early postoperativ..:
Fumery, M
;
Nancey, S
;
Nachury, M
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i166-i167 , 2023
Link:
https://doi.org/10.1093/..
?
7
P443 Risk of incident Cancer in Patients with Inflammatory ..:
Le Cosquer, G
;
Gilletta, C
;
Amiot, A
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i572-i572 , 2023
Link:
https://doi.org/10.1093/..
?
8
P404 Persistence of subcutaneous infliximab after switching..:
Mathieu, N
;
Riviere, P
;
Heluwaert, F
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i533-i534 , 2023
Link:
https://doi.org/10.1093/..
?
9
P638 Effectiveness and safety of risankizumab induction the..:
Fumery, M
;
Defrance, A
;
Roblin, X
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i770-i770 , 2023
Link:
https://doi.org/10.1093/..
?
10
Association entre vascularites des gros vaisseaux et maladi..:
Maillet, F.
;
Abitbol, V.
;
Allain, J.S.
...
La Revue de Médecine Interne. 43 (2022) - p. A126-A127 , 2022
Link:
https://doi.org/10.1016/..
?
11
P142 Inflammatory bowel diseases associated with primary im..:
Malamut, G
;
Simon, M
;
Nachury, M
...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i223-i224 , 2022
Link:
https://doi.org/10.1093/..
?
12
P350 Comparative risk of incident cancer in patients with I..:
Poullenot, F
;
Amiot, A
;
Nachury, M
...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i362-i363 , 2022
Link:
https://doi.org/10.1093/..
?
13
Comparative Risk of Incident Cancer in Patients with Inflam..:
Poullenot, F
;
Amiot, A
;
Nachury, M
...
Journal of Crohn's and Colitis. 16 (2022) 10 - p. 1523-1530 , 2022
Link:
https://doi.org/10.1093/..
?
14
P140 Immunomodulators are protective against severe COVID 1..:
Vuitton, L
;
Bourrier, A
;
Uzzan, M
...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i222-i223 , 2022
Link:
https://doi.org/10.1093/..
?
15
P504 Effectiveness and safety of ustekinumab maintenance th..:
Fumery, M
;
Filippi, J
;
Abitbol, V
...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S486-S487 , 2021
Link:
https://doi.org/10.1093/..
1-15